The trial of a vaccine for Ebola has been started in Mali, with 40 participants. This is part of a larger study started in the UK in September of a vaccine developed by GlaxoSmithKline. This program is a combined effort of the British pharmaceutical company, the World Health Organization (WHO) and the US National Institute of Health.
In Mali, testing of the vaccine has begun on health care workers. About one in 16 of those who have died in Africa